UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhibition of monocyte and polymorphonuclear granulocyte immune phagocytosis by monoclonal antibodies specific for FcγRI, II and III

Annals of hematology, 1997-01, Vol.74 (1), p.15-22

1997

Volltextzugriff (PDF)

The NAnull phenotype of a young man is caused by an FcγRIIIB gene deficiency while the products of the neighboring FcγRIIA and FcγRIIIA genes are present

Annals of hematology, 1998-05, Vol.76 (5), p.215-220

1998

Volltextzugriff (PDF)

The NA"null" phenotype of a young man is caused by an FcγRIIIB gene deficiency while the products of the neighboring FcγRIIA and FcγRIIIA genes are present

Annals of hematology, 1998-06, Vol.76 (5), p.215-220

1998

Volltextzugriff (PDF)

Pharmacokinetics of colchicine: a review of experimental and clinical data

Zeitschrift für Gastroenterologie, 1992-03, Vol.30 Suppl 1, p.35

1992

Volltextzugriff (PDF)

Oral medium-dosed metoclopramide versus placebo as highly effective antiemetic prophylaxis in in- and outpatients on noncisplatin chemotherapy

Oncology, 1993-03, Vol.50 (2), p.81-85

1993

Volltextzugriff (PDF)

Minimal biliary excretion and enterohepatic recirculation of metoclopramide in patients with extrahepatic cholestasis

European journal of clinical pharmacology, 1993-12, Vol.45 (5), p.415-418

1993

Volltextzugriff (PDF)

Pharmacokinetics/bioavailability of colchicine in healthy male volunteers

European journal of drug metabolism and pharmacokinetics, 1989-10, Vol.14 (4), p.317-322

1989

Volltextzugriff (PDF)

Steady state investigation of possible pharmacokinetic interactions of moxonidine and glibenclamide

European journal of drug metabolism and pharmacokinetics, 1993-07, Vol.18 (3), p.277-283

1993

Volltextzugriff (PDF)

Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis

Clinical pharmacology and therapeutics, 1985-01, Vol.37 (1), p.43-47

1985

Volltextzugriff (PDF)

On the complex formation of acridine dyes with DNA. VII. Dependence of the binding on the dye structure

Biopolymers, 1969-11, Vol.8 (5), p.595-608

1969

Volltextzugriff (PDF)

Metabolism of isobutylnaphthyl acetic acid in rats : determination of the chemical structures of metabolites

European journal of drug metabolism and pharmacokinetics, 1989, Vol.14 (1), p.29-34

1989

Volltextzugriff (PDF)

Metabolism and pharmacokinetics of metaclazepam (Talis), Part III: Determination of the chemical structure of metabolites in dogs, rabbits and men

European journal of drug metabolism and pharmacokinetics, 1984-10, Vol.9 (4), p.325-346

1984

Volltextzugriff (PDF)

H39 The pharmacokinetics of moxonidine after single and repeated doses in the elderly

American journal of hypertension, 1997-04, Vol.10 (S2), p.86A-86A

1997

Volltextzugriff (PDF)

Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidation

Klinische Wochenschrift, 1985-11, Vol.63 (22), p.1180-1186

1985

Volltextzugriff (PDF)

The NA"null" phenotype of a young man is caused by an Fc gammaRIIIB gene deficiency while the products of the neighboring Fc gammaRIIA and Fc gammaRIIIA genes are present

Annals of hematology, 1998-05, Vol.76 (5), p.215-220

1998

Volltextzugriff (PDF)

Pharmacokinetics of n-propyl-ajmaline-bitartrate in elderly patients with ventricular ectopic activity

European journal of drug metabolism and pharmacokinetics, 1987, Vol.12 (1), p.77-82

1987

Volltextzugriff (PDF)

Comparison of the pharmacokinetic profile of metaclazepam in old and young volunteers

European journal of clinical pharmacology, 1985-01, Vol.29 (2), p.247-249

1985

Volltextzugriff (PDF)

Pharmacokinetic profile of metaclazepam (Talis ®), a new 1.4-benzodiazepine. Influence of different dosage regimens on the pharmacokinetic profile of metaclazepam and its main metabolite under steady-state conditions

European journal of drug metabolism and pharmacokinetics, 1986-07, Vol.11 (3), p.205-210

1986

Volltextzugriff (PDF)

Determination of revenast hydrochloride in human plasma by gas chromatography with nitrogen-selective detection

Journal of chromatography, 1987, Vol.419, p.351-356

1987

Volltextzugriff (PDF)

Transfer of metaclazepam and its metabolites into breast milk

Arzneimittel-Forschung, 1989-11, Vol.39 (11), p.1468

1989

Volltextzugriff (PDF)

Some properties of an inhibitory cytochrome P-450 metabolic-intermediate complex existing in a spin-state equilibrium

Biochemical pharmacology, 1989-09, Vol.38 (18), p.3037-3043

1989

Volltextzugriff (PDF)

Determination of eproxindine hydrochloride in human plasma by capillary gas chromatography

Journal of chromatography, 1988, Vol.427 (1), p.157-161

1988

Volltextzugriff (PDF)

Alloantiserum Recognizing a DQw2 Split Which Is Associated with DR3

Vox sanguinis, 1991-01, Vol.60 (2), p.123-125

1991

Volltextzugriff (PDF)

Determination of timelotem dihydrogenmaleate and its main metabolite N-desmethyltimelotem in plasma by capillary gas chromatography

Journal of chromatography, 1987, Vol.419, p.357-362

1987

Volltextzugriff (PDF)

Absolute bioavailability of metoclopramide given orally or by enema in patients with normal liver function or with cirrhosis of the liver

Arzneimittel-Forschung, 1987-06, Vol.37 (6), p.733

1987

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(55)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inhibition of monocyte and polymorphonuclear granulocyte immune phagocytosis by monoclonal antibodies specific for FcγRI, II and III

The NAnull phenotype of a young man is caused by an FcγRIIIB gene deficiency while the products of the neighboring FcγRIIA and FcγRIIIA genes are present

The NA"null" phenotype of a young man is caused by an FcγRIIIB gene deficiency while the products of the neighboring FcγRIIA and FcγRIIIA genes are present

Pharmacokinetics of colchicine: a review of experimental and clinical data

Oral medium-dosed metoclopramide versus placebo as highly effective antiemetic prophylaxis in in- and outpatients on noncisplatin chemotherapy

Minimal biliary excretion and enterohepatic recirculation of metoclopramide in patients with extrahepatic cholestasis

Pharmacokinetics/bioavailability of colchicine in healthy male volunteers

Steady state investigation of possible pharmacokinetic interactions of moxonidine and glibenclamide

Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis

On the complex formation of acridine dyes with DNA. VII. Dependence of the binding on the dye structure

Metabolism of isobutylnaphthyl acetic acid in rats : determination of the chemical structures of metabolites

Metabolism and pharmacokinetics of metaclazepam (Talis), Part III: Determination of the chemical structure of metabolites in dogs, rabbits and men

H39 The pharmacokinetics of moxonidine after single and repeated doses in the elderly

Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidation

The NA"null" phenotype of a young man is caused by an Fc gammaRIIIB gene deficiency while the products of the neighboring Fc gammaRIIA and Fc gammaRIIIA genes are present

Pharmacokinetics of n-propyl-ajmaline-bitartrate in elderly patients with ventricular ectopic activity

Comparison of the pharmacokinetic profile of metaclazepam in old and young volunteers

Pharmacokinetic profile of metaclazepam (Talis ®), a new 1.4-benzodiazepine. Influence of different dosage regimens on the pharmacokinetic profile of metaclazepam and its main metabolite under steady-state conditions

Determination of revenast hydrochloride in human plasma by gas chromatography with nitrogen-selective detection

Transfer of metaclazepam and its metabolites into breast milk

Some properties of an inhibitory cytochrome P-450 metabolic-intermediate complex existing in a spin-state equilibrium

Determination of eproxindine hydrochloride in human plasma by capillary gas chromatography

Alloantiserum Recognizing a DQw2 Split Which Is Associated with DR3

Determination of timelotem dihydrogenmaleate and its main metabolite N-desmethyltimelotem in plasma by capillary gas chromatography

Absolute bioavailability of metoclopramide given orally or by enema in patients with normal liver function or with cirrhosis of the liver

Suchergebnisse filtern